drugset / Trial / NCT04913090
A Phase I Clinical Trial of XZP-5610 Tablets in Healthy Subjects
RandomizedParallel-groupDouble-blindTreatment
Summary
This study will consist of 3 parts: Part A - Single Ascending Dose (SAD) phase, Part B - multiple ascending dose (MAD) phase, and Part C - Food Effect (FE) phase.
Timeline
- Start
- 2021-05-31
- Primary completion
- 2022-03-04
- Completion
- 2022-03-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | XZP-5610 | Unknown | — | Oral |